US Congress House Bill 3709 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 6-0)
Status: Introduced on December 11 2013 - 25% progression, died in committee
Action: 2014-01-27 - Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
Pending: House Subcommittee on Courts, Intellectual Property, And The Internet Committee
Text: Latest bill text (Introduced) [PDF]

Protecting Consumer Access to Generic Drugs Act of 2013 - Prohibits, as an unfair and deceptive act or practice and an unfair method of competition in or affecting interstate commerce, any person from being a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market or sell the generic drug. Excludes a resolution or settlement that includes no more than: (1) the right to market the generic drug before the expiration of the patent or other exclusivity period, or (2) the waiver of a patent infringement claim for damages. Authorizes the Federal Trade Commission (FTC) to exempt agreements in furtherance of market competition and for the benefit of consumers. Amends the Federal Food, Drug, and Cosmetic Act to deem an applicant to have forfeited market exclusivity if the applicant enters into an agreement that violates this Act. Amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to revise reporting requirements related to agreements between a generic drug applicant and a brand name drug company to include: (1) a description of the subject matter of other agreements between the parties; and (2) a certification that the materials filed represent the complete, final, and exclusive agreement between the parties.

Protecting Consumer Access to Generic Drugs Act of 2013

Rep. Bobby Rush [D-IL]	Rep. Jared Huffman [D-CA]	Rep. Janice Schakowsky [D-IL]	Rep. Carol Shea-Porter [D-NH]
Sen. Chris Van Hollen [D-MD]	Rep. Henry Waxman [D-CA]

Date	Chamber	Action
2014-01-27	House	Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.
2014-01-27	House	Referred to the Subcommittee on Regulatory Reform, Commercial And Antitrust Law.
2013-12-13	House	Referred to the Subcommittee on Health.
2013-12-11	House	Referred to House Judiciary
2013-12-11	House	Referred to House Energy and Commerce
2013-12-11	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Type	Source
Summary	https://www.congress.gov/bill/113th-congress/house-bill/3709/all-info
Text	https://www.congress.gov/113/bills/hr3709/BILLS-113hr3709ih.pdf